Hyun-Mi Cho

发表

Anti-CD20-interleukin-21 fusokine targets malignant B cells via direct apoptosis and NK-cell-dependent cytotoxicity.

I. Lossos, J. Timmerman, J. Rosenblatt, 2017, Blood.

Inhibition of Vasculogenic Mimicry and Angiogenesis by an Anti-EGFR IgG1-Human Endostatin-P125A Fusion Protein Reduces Triple Negative Breast Cancer Metastases

S. Carroll, S. Ramakrishnan, J. Rosenblatt, 2021, Cells.

Both the epitope specificity and isotype are important in the antitumor effect of monoclonal antibodies against Her‐2/neu antigen

Yeonseok Chung, Hyun-Mi Cho, Seung-uon Shin, 2002, International journal of cancer.

Interferon Alpha‐2a Reduces Early Erythema After Full‐Thickness Skin Graft in the Pig

G. Roh, Daegu Son, Kihwan Han, 2009, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

The absence of B lymphocytes reduces the number and function of T-regulatory cells and enhances the anti-tumor response in a murine tumor model

E. Podack, J. Rosenblatt, Yu Zhang, 2011, Cancer Immunology, Immunotherapy.

Mammary-tumor-educated B cells acquire LAP/TGF-β and PD-L1 expression and suppress anti-tumor immune responses.

R. Morgan, E. Clark, W. Khan, 2016, International immunology.

Lipid Binding Peptides Region of Surface and Core Fraction from Apo B-100 of Human LDL

Y. Jang, K. Hwang, Hyun-Mi Cho, 2022 .

Enhanced inhibition of murine tumor and human breast tumor xenografts using targeted delivery of an antibody-endostatin fusion protein

S. Morrison, M. Penichet, K. Webster, 2005, Molecular Cancer Therapeutics.

Antibodies and antibody-fusion proteins as anti-angiogenic, anti-tumor agents

K. Webster, C. Calfa, J. Rosenblatt, 2006 .

Targeted Delivery of an Antibody–Mutant Human Endostatin Fusion Protein Results in Enhanced Antitumor Efficacy

J. Merchan, S. Ramakrishnan, J. Rosenblatt, 2011, Molecular Cancer Therapeutics.

Increased rejection of primary tumors in mice lacking B cells: Inhibition of anti‐tumor CTL and TH1 cytokine responses by B cells

A. Divekar, B. Segal, J. Rosenblatt, 2005, International journal of cancer.

Model for in vivo progression of tumors based on co-evolving cell population and vasculature

Neil F. Johnson, Guannan Zhao, Zhenyuan Zhao, 2011, Scientific reports.

Targeted Delivery of an Antibody–Mutant Human Endostatin Fusion Protein Results in Enhanced Antitumor Efficacy

J. Merchan, S. Ramakrishnan, J. Rosenblatt, 2011, Molecular Cancer Therapeutics.